Value-based contracts between pharmaceutical manufacturers and payers are a fast-growing, new development that is here to stay. These pharma contracts put in place a reward system - higher payment rates - in exchange for demonstrably improved patient outcomes. This type of agreement is intended to reward healthcare value over volume. Some outcomes can be measured […]